These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 29439669)

  • 41. Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.
    Morris VA; Cummings CL; Korb B; Boaglio S; Oehler VG
    Mol Cell Biol; 2016 Feb; 36(4):559-73. PubMed ID: 26644403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-9 downregulates CDX2 expression in gastric cancer cells.
    Rotkrua P; Akiyama Y; Hashimoto Y; Otsubo T; Yuasa Y
    Int J Cancer; 2011 Dec; 129(11):2611-20. PubMed ID: 21225631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
    Li SM; Zhao YQ; Hao YL; Liang YY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1203-1213. PubMed ID: 30779090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-10b regulates the proliferation and apoptosis of pediatric acute myeloid leukemia through targeting HOXD10.
    Wang CJ; Zou H; Feng GF
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7371-7378. PubMed ID: 30468483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
    Lauber C; Correia N; Trumpp A; Rieger MA; Dolnik A; Bullinger L; Roeder I; Seifert M
    Sci Rep; 2020 Jul; 10(1):12761. PubMed ID: 32728112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
    Li Z; Huang H; Li Y; Jiang X; Chen P; Arnovitz S; Radmacher MD; Maharry K; Elkahloun A; Yang X; He C; He M; Zhang Z; Dohner K; Neilly MB; Price C; Lussier YA; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Bullinger L; Valk PJ; Delwel R; Lowenberg B; Liu PP; Marcucci G; Bloomfield CD; Rowley JD; Chen J
    Blood; 2012 Mar; 119(10):2314-24. PubMed ID: 22251480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.
    Schulze I; Rohde C; Scheller-Wendorff M; Bäumer N; Krause A; Herbst F; Riemke P; Hebestreit K; Tschanter P; Lin Q; Linhart H; Godley LA; Glimm H; Dugas M; Wagner W; Berdel WE; Rosenbauer F; Müller-Tidow C
    Blood; 2016 Mar; 127(12):1575-86. PubMed ID: 26729896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis.
    Hu X; Xu S; Chen Y; Gao Z; Li Y; Hu J; Huang X; Zhang Y; Jiang X; Li L; Yang C; Chen J; Gao N
    Leukemia; 2019 May; 33(5):1090-1101. PubMed ID: 30518811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.
    Mangiavacchi A; Sorci M; Masciarelli S; Larivera S; Legnini I; Iosue I; Bozzoni I; Fazi F; Fatica A
    Oncotarget; 2016 Sep; 7(37):60155-60168. PubMed ID: 27517498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
    Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G
    Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of DNMT3b contributes to HOTAIRM1 silencing via DNA hypermethylation in cells transformed by long-term exposure to hydroquinone and workers exposed to benzene.
    Zhang H; Yuan Q; Pan Z; Ling X; Tan Q; Wu M; Zheng D; Xie P; Xie D; Liu L
    Toxicol Lett; 2020 Apr; 322():12-19. PubMed ID: 31899212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis.
    Greenblatt SM; Man N; Hamard PJ; Asai T; Karl D; Martinez C; Bilbao D; Stathias V; Jermakowicz AM; Duffort S; Tadi M; Blumenthal E; Newman S; Vu L; Xu Y; Liu F; Schurer SC; McCabe MT; Kruger RG; Xu M; Yang FC; Tenen DG; Watts J; Vega F; Nimer SD
    Cancer Cell; 2018 Jun; 33(6):1111-1127.e5. PubMed ID: 29894694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
    Palakurthy RK; Wajapeyee N; Santra MK; Gazin C; Lin L; Gobeil S; Green MR
    Mol Cell; 2009 Oct; 36(2):219-30. PubMed ID: 19854132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    Bao F; Zhang L; Pei X; Lian C; Liu Y; Tan H; Lei P
    PLoS One; 2021; 16(9):e0256995. PubMed ID: 34587164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways.
    Fang ZH; Wang SL; Zhao JT; Lin ZJ; Chen LY; Su R; Xie ST; Carter BZ; Xu B
    Cell Death Dis; 2016 Sep; 7(9):e2371. PubMed ID: 27899822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA LINC00641 promotes cell growth and migration through modulating miR-378a/ZBTB20 axis in acute myeloid leukemia.
    Wang J; Liu ZH; Yu LJ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7498-7509. PubMed ID: 31539138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-204 suppresses the progression of acute myeloid leukemia through HGF/c-Met pathway.
    Nie D; Ma P; Chen Y; Zhao H; Liu L; Xin D; Cao W; Wang F; Meng X; Liu L; Xie M; Sun L
    Hematology; 2021 Dec; 26(1):931-939. PubMed ID: 34789086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer.
    Li Q; Zhu F; Chen P
    Biochem Biophys Res Commun; 2012 Jul; 424(1):28-33. PubMed ID: 22705304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ectopic DNMT3B expression delays leukemogenesis.
    Stanley RF; Steidl U
    Blood; 2016 Mar; 127(12):1525-6. PubMed ID: 27013212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.